C78.0 - Secondary malignant neoplasm of lung

Version 2023
ICD-10:C78.0
Short Description:Secondary malignant neoplasm of lung
Long Description:Secondary malignant neoplasm of lung
Status: Not Valid for Submission
Version:ICD-10-CM 2023
Code Classification:
  • Neoplasms (C00–D48)
    • Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80)
      • Secondary malignant neoplasm of resp and digestive organs (C78)

C78.0 is a non-specific and non-billable ICD-10 code code, consider using a code with a higher level of specificity for a diagnosis of secondary malignant neoplasm of lung. The code is not specific and is NOT valid for the year 2023 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic bronchiogenic, bronchogenic (lung) ; Neoplasm, neoplastic bronchiole ; Neoplasm, neoplastic bronchus ; Neoplasm, neoplastic bronchus carina ; Neoplasm, neoplastic bronchus lower lobe of lung ; Neoplasm, neoplastic bronchus main ; Neoplasm, neoplastic bronchus middle lobe of lung ; etc

Specific Coding for Secondary malignant neoplasm of lung

Non-specific codes like C78.0 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for secondary malignant neoplasm of lung:

  • BILLABLE CODE - Use C78.00 for Secondary malignant neoplasm of unspecified lung
  • BILLABLE CODE - Use C78.01 for Secondary malignant neoplasm of right lung
  • BILLABLE CODE - Use C78.02 for Secondary malignant neoplasm of left lung

Table of Neoplasms

This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »bronchiogenic, bronchogenic (lung)
C34.9C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »bronchiole
C34.9C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »bronchus
C34.9C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »bronchus
    »carina
C34.0C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »bronchus
    »lower lobe of lung
C34.3C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »bronchus
    »main
C34.0C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »bronchus
    »middle lobe of lung
C34.2C78.0D02.21D14.31D38.1D49.1
»Neoplasm, neoplastic
  »bronchus
    »upper lobe of lung
C34.1C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »carina (bronchus)
C34.0C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »hilus of lung
C34.0C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lingula, lung
C34.1C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
C34.9C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »azygos lobe
C34.1C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »carina
C34.0C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »hilus
C34.0C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »linqula
C34.1C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »lobe NEC
C34.9C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »lower lobe
C34.3C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »main bronchus
C34.0C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »middle lobe
C34.2C78.0D02.21D14.31D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »upper lobe
C34.1C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »pulmonary [See Also: Neoplasm, lung]
C34.9C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »subpleural
C34.9C78.0D02.2D14.3D38.1D49.1

Patient Education


Lung Cancer

What is lung cancer?

Lung cancer is cancer that forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.

There are two main types: small cell lung cancer and non-small cell lung cancer. These two types grow differently and are treated differently. Non-small cell lung cancer is the more common type.

Who is at risk for lung cancer?

Lung cancer can affect anyone, but there are certain factors that raise your risk of getting it:

What are the symptoms of lung cancer?

Sometimes lung cancer does not cause any signs or symptoms. It may be found during a chest x-ray done for another condition.

If you do have symptoms, they may include:

How is lung cancer diagnosed?

Your health care provider may use many tools to make a diagnosis:

If you do have lung cancer, your provider will do other tests to find out how far it has spread through the lungs, lymph nodes, and the rest of the body. This is called staging. Knowing the type and stage of lung cancer you have helps your provider decide what kind of treatment you need.

What are the treatments for lung cancer?

For most patients with lung cancer, current treatments do not cure the cancer.

Your treatment will depend on which type of lung cancer you have, how far it has spread, your overall health, and other factors. You may get more than one type of treatment.

The treatments for small cell lung cancer include:

The treatments for non-small cell lung cancer include:

Can lung cancer be prevented?

Avoiding the risk factors may help to prevent lung cancer:

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Non-Small Cell Lung Cancer Summary

Learn about non-small cell lung cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Lung Cancer

What is lung cancer?

Lung cancer is cancer that forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.

There are two main types: small cell lung cancer and non-small cell lung cancer. These two types grow differently and are treated differently. Non-small cell lung cancer is the more common type.

Who is at risk for lung cancer?

Lung cancer can affect anyone, but there are certain factors that raise your risk of getting it:

What are the symptoms of lung cancer?

Sometimes lung cancer does not cause any signs or symptoms. It may be found during a chest x-ray done for another condition.

If you do have symptoms, they may include:

How is lung cancer diagnosed?

Your health care provider may use many tools to make a diagnosis:

If you do have lung cancer, your provider will do other tests to find out how far it has spread through the lungs, lymph nodes, and the rest of the body. This is called staging. Knowing the type and stage of lung cancer you have helps your provider decide what kind of treatment you need.

What are the treatments for lung cancer?

For most patients with lung cancer, current treatments do not cure the cancer.

Your treatment will depend on which type of lung cancer you have, how far it has spread, your overall health, and other factors. You may get more than one type of treatment.

The treatments for small cell lung cancer include:

The treatments for non-small cell lung cancer include:

Can lung cancer be prevented?

Avoiding the risk factors may help to prevent lung cancer:

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Non-Small Cell Lung Cancer Summary

Learn about non-small cell lung cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Code History

  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)